Joint Corp

Joint Corp(JYNT)股票分析

$8.360

-0.079 (-0.95%)收盘时

Loading chart…
High
8.500
Open
8.415
VWAP
8.38
Vol
68.48K
Mkt Cap
204.84M
Low
8.295
Amount
574.25K
EV/EBITDA, TTM
26.41

The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.

AI analysis of Joint Corp (JYNT)

hold

Joint Corp (JYNT) is currently priced at $8.43, which is below the analyst price target of $12, indicating potential upside. However, the stock has a relatively high forward P/E of 19.88, suggesting it may be overvalued at this price point. The recent insider buying activity increased by 24955.71%, signaling strong confidence from insiders, but the stock's RSI of 49.52 indicates a neutral momentum. The main risk is the recent earnings report where EPS was -0.01, missing estimates by 109.09%, which could impact investor sentiment negatively.

Analyst Ratings (3)

+35.53% upside
Buy
3 Buy
0 Hold
0 Sell
Current: 8.36
最低
9.00
平均
11.33
最高
14.00

Roth Capital

2026-03-13

目标价

$12

Buy

B. Riley

2025-11-07

目标价

$9

Neutral

Lake Street

2025-11-07

目标价

$11

Buy

Roth Capital

2025-11-07

目标价

$14

Buy

Lake Street

2025-05-09

目标价

$16

Buy

估值指标

The current forward P/E ratio for Joint Corp (JYNT) is 19.61, compared to its 5-year average forward P/E of 95.38.

Forward P/E

Fair
5Y Average P/E
95.38
Current P/E
19.61
高估
195.02
低估
-4.25

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
27.20
Current EV/EBITDA
26.41
高估
53.25
低估
1.15

Forward P/S

Fair
5Y Average P/S
2.98
Current P/S
1.90
高估
5.97
低估
0.00

Alphio AI Price Scenarios for JYNT

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%JYNT

$10.79

情景价格

B

Base

Base · 50%JYNT

$9.39

情景价格

B

Bear

Bear · 25%JYNT

$8.24

情景价格

事件时间线

2026-08-06 (ET)

17:30:00

Company Expects System-wide Sales Between $519 Million and $552 Million

17:30:00

The Joint Corp. Reports Q2 Revenue of $15.18M

2026-05-07 (ET)

17:30:00

The Joint Corp. Q1 Revenue $14.82M, Exceeds Expectations

17:30:00

Company Expects 30 to 35 New Franchise Clinics Openings

2026-04-27 (ET)

16:30:00

Joint Corp. Sells 45 Clinics to Elite Chiro Group for $2.3M

资讯

JYNT FAQ — answered by Alphio AI

The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations. It operates in the Healthcare sector (PATENT OWNERS & LESSORS industry).

Joint Corp (JYNT) is currently priced at $8.43, which is below the analyst price target of $12, indicating potential upside. However, the stock has a relatively high forward P/E of 19.88, suggesting it may be overvalued at this price point. The recent insider buying activity increased by 24955.71%, signaling strong confidence from insiders, but the stock's RSI of 49.52 indicates a neutral momentum. The main risk is the recent earnings report where EPS was -0.01, missing estimates by 109.09%, which could impact investor sentiment negatively.

3 analysts cover JYNT: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 11.33.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始